Dr. Ivan E. Porter Jr., MD

Dr. Porter practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Porter's NPI, 1679737563, was assigned on July 10, 2008. Dr. Porter graduated from Florida State University College Of Medicine in 2008. Dr. Porter holds Florida license ME105068.

Dr. Porter's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Porter's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Porter practices. Vendor and product names are available with a free account.

Nephrology is Dr. Porter's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Porter is board certified in internal medicine by the American Board of Internal Medicine. Dr. Porter is licensed in Florida.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia, kidney failure and parathyroid gland disorder among the conditions Dr. Porter treats.

CMS data shows 460 Medicare services from Dr. Porter across 6 procedure codes in 2024, for 266 Medicare patients. Medicare paid $45,967 for them.

CMS counts 266 Medicare patients who saw Dr. Porter in 2026. The largest group is 65 to 74, with 107 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 4.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Porter's median patient age at 60, with 58% women.

In 2026, Dr. Porter wrote 197 Medicare Part D claims for 38 patients. 88% of them were for generic drugs. CMS names the drug for 95 of them, across 6 drugs with 11 or more claims each, at $89,252 in total drug cost. In 2023, CMS named 65 claims across 4 drugs.

Dr. Porter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Porter as offering telehealth.

Dmand AI links 15 papers to Dr. Porter, published from 2016 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Oxalates. Dr. Porter has published most often in BMJ Case Rep. Dr. Porter's most frequent co-authors are Shipra Arya, MD, Albert Bui, DO and Cherise Cortese, MD.

Dmand AI links Dr. Porter to 1 clinical trial. Conditions studied include Glomerulonephritis, Membranous and Glomerulonephritis.

CMS Open Payments shows 12 general payments to Dr. Porter from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. NxStage Medical, Inc. paid the most, $144. It also lists 8 research payments totaling $1,084 in 2016.

Dr. Porter serves on MMS Social Media Committee.

Dr. Porter graduated from Florida State University College Of Medicine in 2008. Dr. Porter is a member of ACP.

Dr. Porter is in network with 7 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. POS plans come from the most carriers, 4. Check the plan with the practice before a visit.